Form 4: Inari Medical CFO Kevin T. Strange Reports Stock Disposals to Cover Tax Obligations

Chief Financial Officer of Inari Medical, Kevin T. Strange, reports disposing of shares to cover tax obligations related to vesting restricted share units.

Summary

• Kevin T. Strange, the CFO of Inari Medical, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the disposal of common stock to satisfy tax obligations related to the vesting of restricted share units.
• These shares were retained by Inari Medical to cover the tax liabilities associated with restricted share units awarded in 2021, 2022, 2023 and 2024.
• The transactions occurred on January 1, 2025, with a price of $51.05 per share.
• Following the reported transactions, Strange directly owns 46,318 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions for tax purposes. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates the CFO's stock disposal to cover tax obligations, which is a common practice.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but it is unlikely to be significant given the relatively small number of shares involved.

Key Dates